Showing results (121-130 of 610) with videos related to
Sort By:
Pageof 61
Circulation|November 1, 1990
Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis modelD Collen, M Dewerchin, H J Rapold, et al.Thrombosis and Haemostasis|October 31, 1988
Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activatorH R Lijnen, L Nelles, B Van Hoef, et al.European Journal of Biochemistry|April 15, 1992
Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with AlaH R Lijnen, X K Li, L Nelles, et al.The Journal of Biological Chemistry|April 5, 1990
Biochemical and functional characterization of human tissue-type plasminogen activator variants obtained by deletion and/or duplication of structural/functional domainsH R Lijnen, L Nelles, B Van Hoef, et al.Thrombosis and Haemostasis|August 6, 2000
Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alphaB Arza, J Félez, P Fábregas, et al.Thrombosis and Haemostasis|January 1, 1994
Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activatorS Ueshima, P Holvoet, H R Lijnen, et al.Thrombosis and Haemostasis|August 20, 1986
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitroD Collen, F De Cock, E Demarsin, et al.Circulation|September 1, 1991
Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activatorsD Collen, H R Lu, H R Lijnen, et al.Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in miceH R Lijnen, M-C Alessi, B Van Hoef, et al.The Journal of Biological Chemistry|July 25, 1990
Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domainsD Collen, H R Lijnen, F Bulens, et al.Pageof 61